These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22118971)

  • 21. Prevention of osteoporotic fractures in the elderly.
    Wilkins CH; Birge SJ
    Am J Med; 2005 Nov; 118(11):1190-5. PubMed ID: 16271899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thyrotoxicosis revelated by bilateral hip fracture].
    Sahli H; Cheour E; Metoui L; Frini S; Meddeb N; Sellami S
    Tunis Med; 2006 Jun; 84(6):382-4. PubMed ID: 17042215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rational approach to evidence gaps in the management of osteoporosis.
    Rosen CJ; Brown SA
    Am J Med; 2005 Nov; 118(11):1183-9. PubMed ID: 16271898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective.
    Boonen S; Dejaeger E; Vanderschueren D; Venken K; Bogaerts A; Verschueren S; Milisen K
    Best Pract Res Clin Endocrinol Metab; 2008 Oct; 22(5):765-85. PubMed ID: 19028356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recognition of women at risk for fracture and intervention with fast-acting therapies.
    Derman R
    Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G; Ziegler R
    Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.
    Boonen S; Klemes AB; Zhou X; Lindsay R
    J Am Geriatr Soc; 2010 Apr; 58(4):658-63. PubMed ID: 20345865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmenopausal osteoporosis: fracture risk and prevention.
    Kaunitz AM; McClung MR; Feldman RG; Wysocki S
    J Fam Pract; 2009 Nov; 58(11 Suppl Postmenopausal):S1-6. PubMed ID: 19891943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).
    Jakob F; Marín F; Martín-Mola E; Torgerson D; Fardellone P; Adami S; Thalassinos NC; Sykes D; Melo-Gomes J; Chinn C; Nicholson T; Cooper C
    QJM; 2006 Aug; 99(8):531-43. PubMed ID: 16861718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Older women with osteoporosis have increased postural sway and weaker quadriceps strength than counterparts with normal bone mass: overlooked determinants of fracture risk?
    Liu-Ambrose T; Eng JJ; Khan KM; Carter ND; McKay HA
    J Gerontol A Biol Sci Med Sci; 2003 Sep; 58(9):M862-6. PubMed ID: 14528046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fracture panorama in Umea].
    Bergström U; Björnstig U; Svensson O
    Lakartidningen; 2006 Oct 4-10; 103(40):2967-8. PubMed ID: 17115659
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiresorptive agents, raloxifene, and PHARMAC.
    Gilchrist N
    N Z Med J; 2006 Mar; 119(1230):U1885. PubMed ID: 16532050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of osteoporosis in different life stages and conditions].
    Ohta H
    Clin Calcium; 2014 Mar; 24(3):391-400. PubMed ID: 24576936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insufficiency fracture of the femoral neck during osteoporosis treatment: a case report.
    Iwamoto J; Takeda T
    J Orthop Sci; 2002; 7(6):707-12. PubMed ID: 12486478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Frontiers in vitamin D; basic Research and clinical application. Effect of active vitamin D3 on osteoporosis].
    Yamauchi M; Sugimoto T
    Clin Calcium; 2011 Nov; 21(11):17-24. PubMed ID: 22040817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition and treatment of postmenopausal osteoporosis.
    Hannafon F; Cadogan MP
    J Gerontol Nurs; 2014 Mar; 40(3):10-4. PubMed ID: 24696876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
    Silverman SL; Shen W; Minshall ME; Xie S; Moses KH
    J Rheumatol; 2007 Jan; 34(1):140-4. PubMed ID: 17216681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of fragility fractures.
    Tarantino U; Cannata G; Lecce D; Celi M; Cerocchi I; Iundusi R
    Aging Clin Exp Res; 2007 Aug; 19(4 Suppl):7-11. PubMed ID: 18182886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture.
    Miller RG
    Geriatrics; 2006 Jan; 61(1):24-30. PubMed ID: 16405361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.